Assessing taxane-associated adverse events using the FDA adverse event reporting system database

Samankaltaisia teoksia

• Causes of drug-induced photosensitivity: an analysis using FDA adverse event reporting system database
  Tekijä: Lele Ge, et al.
  Julkaistu: (2025-05-01)
• Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
  Tekijä: Chang-Zhu He, et al.
  Julkaistu: (2025-03-01)
• Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
  Tekijä: Iarikov, Dmitri, et al.
  Julkaistu: (2015)
• Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
  Tekijä: Meng, Long, et al.
  Julkaistu: (2021)
• Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
  Tekijä: Zhuomiao Lin, et al.
  Julkaistu: (2025-08-01)